Royal Canin Launches AI Diagnostic Tool in Mexico, Showcasing Mars' Accelerator-to-Distribution Pipeline

Royal Canin is rolling out GekkoVet's AI-powered clinical decision support software to veterinary practices across Mexico, marking the partnership's first expansion into Latin America. The move is worth watching less for the geography and more for the playbook: a Finnish startup that came through Mars Petcare's own accelerator program is now being distributed globally by Mars's nutrition division. For vet tech founders and clinic operators alike, this is a case study in how the pet industry's largest company is building its technology stack.

What Happened

Royal Canin Mexico announced on February 19 that it will equip veterinary teams across the country with GekkoVet's clinical decision support platform, which provides real-time diagnostic assistance, treatment recommendations, and drug information. The platform draws on more than 33,000 symptom-diagnosis combinations built from over 50,000 pages of clinical source material.

Mexico is the partnership's first national rollout in Latin America, following deployments in Asia earlier this year. The announcement follows a pilot phase where 92% of participating veterinarians reported that GekkoVet improved clinical efficiency and had a positive impact on clinic revenue.

"This launch in Mexico is a major step forward, not just regionally, but globally," said Johanna Majamaa, DVM and co-founder of GekkoVet. Cesar Gutierrez, Marketing and Sales Director at Royal Canin Mexico, added that the collaboration "reflects our commitment to combining nutrition and technology to support veterinary professionals in delivering the best possible care."

GekkoVet, founded in Helsinki in 2018, graduated from Leap Venture Studio Cohort 8, Mars Petcare's startup accelerator. The program provided $200,000 in funding and direct access to Mars's pet care ecosystem. The company does not appear to have raised significant venture capital beyond the Leap grant and early angel backing.

Why It Matters

The surface-level story is a software launch in a new market. The deeper story is about how Mars is constructing an integrated veterinary technology layer across its global operations.

1. Mars's startup pipeline is producing. Leap Venture Studio has accelerated over 40 pet care startups since its founding, with portfolio companies collectively raising over $170 million in follow-on capital. GekkoVet's trajectory from accelerator participant to global distribution partner illustrates the pipeline working as designed: Mars identifies promising tools, provides capital and mentorship, then deploys the winners through its existing sales infrastructure. Royal Canin's sales teams are already inside veterinary clinics selling therapeutic nutrition; adding a software tool to that visit is almost zero marginal cost.

2. This deepens Mars's vertical integration in veterinary care. Mars already owns the largest veterinary hospital network in the world through VCA (acquired for $9.1 billion in 2017), Banfield Pet Hospital (a Mars practice since 2007), and BluePearl emergency and specialty hospitals. It makes therapeutic and prescription diets through Royal Canin. Now it's embedding clinical decision support software into independent practices, extending its influence beyond its own hospital walls. The combined footprint spans hospitals, nutrition, diagnostics, and now clinical software.

3. The distribution model matters more than the technology. GekkoVet is a solid product, but clinical decision support is not a new category. What's novel is the distribution: a nutrition company deploying diagnostic software through its existing sales relationships. Independent vet tech startups selling directly to clinics face a different competitive calculus when the alternative is "free tool from the company that already supplies your prescription diets." Operators evaluating clinical software should understand who's behind the tools being offered and what incentives shape the recommendations.

4. Mexico is a strategic beachhead for Latin America. Mexico's veterinary healthcare market is valued at roughly $1.2 to $1.7 billion, depending on the source, and is growing at 6 to 8% annually. Approximately 70% of Mexican households own at least one pet, one of the highest rates globally. The broader Latin American veterinary market is projected to reach $8.8 billion by 2033. Royal Canin and GekkoVet have indicated additional national launches across the continent will follow. For companies building vet tech products for emerging markets, Mars is establishing the infrastructure first.

What to Watch

Expanded LatAm rollouts. Mexico is explicitly positioned as the first market, with additional countries expected. Watch for Brazil, the region's largest pet market, as the next likely target. The pace of expansion will signal whether this is a real strategic priority or a test-and-learn exercise.

Product integration depth. The critical question is whether GekkoVet's recommendations remain clinically neutral or begin favoring Royal Canin products in treatment pathways. Clinical decision support tools that recommend specific nutrition protocols have obvious cross-sell potential. How this is handled will determine whether the tool builds trust or generates pushback from independent veterinarians.

Competitive response from vet tech platforms. Companies like VetConnect Plus (IDEXX), Antech (Mars, via its diagnostics arm), and independent clinical platforms now face a competitor that bundles software with nutrition sales. Watch for consolidation or partnership announcements as standalone vet tech companies seek distribution advantages of their own.

Leap Venture Studio's next cohort. With Cohort 10 applications open through March 2026, the accelerator continues to funnel startups into Mars's ecosystem. The GekkoVet trajectory gives founders a concrete template: build a product that solves a clinical workflow problem, enter through Leap, and scale through Mars's distribution. For competing accelerators and corporate venture arms in pet care, this is the benchmark to beat.

Source: GekkoVet and Royal Canin Mexico launch via Business Wire